Trial Profile
Cohort Study to Evaluate the Efficacy and Safety of Postoperative Adjuvant Therapy in HER2 Positive Elderly Breast Cancer Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2019
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms Cohort Study accompanying with N-SAS BC07/RESPECT
- 09 Jan 2019 Status changed from active, no longer recruiting to completed.
- 03 Aug 2017 New trial record